Check-Cap (CHEK) Live Share Price, Invest From India

Check-Cap Stock Performance

as on November 27, 2025 at 7:59 am IST

Day's Low
Day's High
$1.50
Day's Price Range
$1.67
$1.62
7.41%
Downside
3.09%
Upside
52 Week's Low
52 Week's High
$1.21
52-Week Price Range
$2.10
$1.62
25.31%
Downside
29.63%
Upside

Check-Cap share price movements today

Previous Close: $1.58
Open: $1.57
Volume: 293.4K
Day's Low - High: $1.50 - $1.67
52 Week Low - High: $1.21 - $2.10

Check-Cap Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Check-Cap Stock Fundamentals & Key Indicators

Check Check-Cap market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

0.00

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Check-Cap vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Check-Cap with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Check-Cap	Hold	$-	NA	NA	0.00%	0.00%
Idexx Laboratories	StrongBuy	$43.4B	7.35%	38.71	62.45%	0.00%
Thermo Fisher	StrongBuy	$257.7B	6.27%	36.70	41.44%	0.26%
IQVIA Holdings	StrongBuy	$44.1B	1.51%	32.13	26.46%	0.00%
Agilent	StrongBuy	$49.3B	8.72%	34.36	53.73%	0.58%

See all

Analyst Recommendation on Check-Cap Stock

Based on 6 analysts

HOLD

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'HOLD' rating for Check-Cap. Average target price of $7

Check-Cap Share Price Target

Get share price movements and forecasts by analysts on Check-Cap.

What analysts predicted

76.86%UPSIDE

Target Price

Current Price

$1.62

Analyzed by

6 Analysts

Target

$7.00

Check-Cap target price $7, a slight upside of 76.86% compared to current price of $1.62. According to 6 analysts rating.

Check-Cap Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Total Revenue	-	-	-	-	-	-	-
Gross Profit	-	-	-	0	0	-	-
Operating Income	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-
Net Income	-4	-4	-4	-4	-6	-2	-3
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Check-Cap Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	-
Operating Income	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-
Net Income	-8	-9	-10	-13	-13	-17	-19	-17	-25
Net Profit Margin	-3617.21%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Check-Cap

Check out the Institutions with significant holdings in Check-Cap.

Funds	Holdings
UBS Group AG	0.01%
Royal Bank of Canada	0.00%
SBI Securities Co Ltd	0.00%
Citadel Advisors Llc	0.00%
Morgan Stanley - Brokerage Accounts	0.09%

See all

Insights on Check-Cap

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CHEK stock has moved up by 23.8%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, CHEK has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Idexx Laboratories, Inc. has given 84.8% return, outperforming this stock by 130.0%

About Check-Cap

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Organisation

Check-Cap

FAQs

What is Check-Cap share price today?

Check-Cap share price today is $1.62 as on November 27, 2025 at 2:29 am IST. Check-Cap share today touched a day high of $1.67 and a low of $1.50.

What is the 52 week high and 52 week low for Check-Cap share?

Check-Cap share touched a 52 week high of $2.10 on November 17, 2025 and a 52 week low of $1.21 on November 6, 2025. Check-Cap stock price today i.e. November 27, 2025 at 2:29 am IST is trending at $1.62,which is 22.86% down from its 52 week high and 33.88% up from its 52 week low.

How to invest in Check-Cap Stock (CHEK) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Check-Cap on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Check-Cap Stock (CHEK) from India?

Indian investors can start investing in Check-Cap (CHEK) shares with as little as ₹94.63999938964844 or $1 (as of November 5, 2026 at 12:03 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.40 in Check-Cap stock (as per the Rupee-Dollar exchange rate as on November 5, 2026 at 12:03 am IST). Based on Check-Cap share’s latest price of $1.62 as on November 27, 2025 at 2:29 am IST, you will get 6.1728 shares of Check-Cap. Learn more about fractional shares .